For a patient who is paced only from the right ventricle, what are the criteria and recommended steps for upgrading to cardiac resynchronization therapy with defibrillator (CRT‑D)?

Upgrading Right Ventricular Pacing to CRT-D

For patients with only right ventricular pacing, upgrade to CRT is indicated (Class IIa) when LVEF ≤35% and anticipated ventricular pacing ≥40%, regardless of baseline QRS duration. 1, 2, 3

Key Criteria for CRT Upgrade

Primary Indications (Class IIa - Level of Evidence: C)

CRT can be useful for patients on guideline-directed medical therapy (GDMT) who have:

• LVEF ≤35%
• Anticipated requirement for significant (≥40%) ventricular pacing 1, 2

This recommendation was upgraded from Class IIb to Class IIa in the 2012 guidelines, reflecting stronger evidence that chronic RV pacing induces left ventricular dyssynchrony with deleterious effects on cardiac function 1, 2.

Additional Considerations for Atrial Fibrillation

If the patient has atrial fibrillation with LVEF ≤35%, CRT upgrade is also Class IIa when:

• The patient requires ventricular pacing OR otherwise meets CRT criteria, AND
• AV nodal ablation or pharmacologic rate control will allow near 100% ventricular pacing with CRT 1, 2, 3

The emphasis on achieving near-complete biventricular capture is critical—partial CRT pacing provides minimal benefit 4.

Clinical Assessment Algorithm

Step 1: Verify Pacing Burden

• Check device interrogation for percentage of ventricular pacing
• If already ≥40% RV pacing or anticipated to be ≥40%, proceed to Step 2
• Progressive QRS widening over time (ΔpQRSd >6 ms) predicts higher likelihood of needing upgrade 5

Step 2: Assess Left Ventricular Function

• Measure LVEF by echocardiography
• If LVEF ≤35%, proceed to Step 3
• Note: Patients may develop pacing-induced cardiomyopathy even with initially normal LVEF 6, 7

Step 3: Optimize Medical Therapy

• Ensure patient is on GDMT for at least 3 months 8
• Reassess LVEF after optimization
• If LVEF remains ≤35%, proceed to Step 4

Step 4: Evaluate Functional Status and Prognosis

• Assess NYHA functional class
• Confirm reasonable expectation of survival with good functional capacity >1 year 1, 2, 3
• If comorbidities/frailty limit survival to <1 year, CRT is not indicated (Class III) 2

Step 5: Choose CRT-P vs CRT-D

• CRT-D is preferred for most patients meeting criteria, as trials predominantly used CRT-D 3, 9
• CRT-P may be appropriate when:
  • Patient has no ICD indication
  • Clinical reasons or personal wishes favor pacemaker over defibrillator
  • Goal is primarily symptom improvement and quality of life 2

Expected Outcomes from Upgrade

The evidence for upgrading RV-paced patients to CRT is robust:

Clinical Improvements 6, 7:

• NYHA class improvement (average reduction from 3.3 to 2.5)
• Six-minute walk distance increase (246m to 321m)
• Hospitalization rate reduction (1.4 to 0.7 admissions per 6 months)

Cardiac Remodeling 6, 7:

• LVEF increase (26% to 31%)
• Left ventricular end-systolic volume reduction (134 mL to 112 mL)
• QRS duration reduction (average 28-38 ms)

Importantly, patients upgraded from RV pacing achieve comparable improvements to de novo CRT implantation in those with intrinsic conduction abnormalities 7.

Critical Pitfalls to Avoid

1. Don't wait for severe symptoms: Patients with chronic RV pacing should be monitored closely, and upgrade should be considered promptly when moderate or severe heart failure develops 6. Progressive ventricular dysfunction may occur insidiously.

2. Ensure adequate biventricular pacing percentage: Post-upgrade, verify that biventricular pacing is occurring ≥95% of the time 4. Inadequate capture negates CRT benefit. Watch for T-wave oversensing that can reduce effective pacing 10.

3. Don't ignore narrow QRS patients: Unlike de novo CRT where QRS duration matters significantly, the upgrade indication applies regardless of baseline QRS duration when pacing burden is high 4, 11. The RV-paced QRS itself creates the dyssynchrony.

4. Consider upfront CRT in high-risk patients: For patients requiring pacemaker implantation who have baseline LVEF ≤35% and will require frequent ventricular pacing, consider de novo CRT rather than conventional pacemaker to avoid future upgrade 3, 12.

Monitoring Strategy

For patients with conventional RV pacemakers who don't yet meet upgrade criteria:

• Serial echocardiography every 6-12 months
• Monitor paced QRS duration on routine ECGs—progressive widening (>6 ms increase) is a marker for future CRT need 5
• Track ventricular pacing burden at device checks
• Assess for heart failure symptoms at each visit